1,3-Dicyclohexylurea
1,3-Dicyclohexylurea (DCU) is an orally active and potent sEH (soluble epoxide hydrolase) inhibitor. Oral Delivery of 1,3-Dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive Rats[1].
Product Specifications
CAS Number
[2387-23-7]
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Epoxide Hydrolase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/1-3-dicyclohexylurea.html
Purity
99.85
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C) |Ethanol : ≥ 2.5 mg/mL
Smiles
O=C(NC1CCCCC1)NC2CCCCC2
Molecular Formula
C13H24N2O
Molecular Weight
224.35
Precautions
H302, H315, H319, H335
References & Citations
[1]Ghosh S, et al. Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. Basic Clin Pharmacol Toxicol. 2008 May;102 (5) :453-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3068607 1.0 µg DNA
Vmn1r191 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details 
MBS1211821-01 0.02 mg (E-Coli)
Recombinant Cygnodraco mawsoni Hemoglobin subunit alpha (hba)
Sign In for Pricing
View Details MBS1211821-02 0.1 mg (E-Coli)
Recombinant Cygnodraco mawsoni Hemoglobin subunit alpha (hba)
Sign In for Pricing
View Details MBS1211821-03 0.02 mg (Yeast)
Recombinant Cygnodraco mawsoni Hemoglobin subunit alpha (hba)
Sign In for Pricing
View Details